Silencing mitogen-activated protein kinase-activated protein kinase-2 arrests inflammatory bone loss.
about
Differential expression of mitogen activating protein kinases in periodontitis.Sexual Dimorphism in MAPK-Activated Protein Kinase-2 (MK2) Regulation of RANKL-Induced Osteoclastogenesis in Osteoclast Progenitor Subpopulations.MAPK usage in periodontal disease progression.Oral inflammatory diseases and systemic inflammation: role of the macrophage.Sustained mitogen-activated protein kinase activation with Aggregatibacter actinomycetemcomitans causes inflammatory bone lossMitogen-Activated Protein Kinase 2 Signaling Shapes Macrophage Plasticity in Aggregatibacter actinomycetemcomitans-Induced Bone Loss.Simvastatin inhibits lipopolysaccharide-induced osteoclastogenesis and reduces alveolar bone loss in experimental periodontal diseaseAlveolar bone loss: mechanisms, potential therapeutic targets, and interventions.JNK signaling plays an important role in the effects of TNF-α and IL-1β on in vitro osteoblastic differentiation of cultured human periosteal-derived cells.Aggregatibacter actinomycetemcomitans, a potent immunoregulator of the periodontal host defense system and alveolar bone homeostasis.The Role of Mitogen-Activated Protein Kinase-Activated Protein Kinases (MAPKAPKs) in Inflammation.Tristetraprolin regulates interleukin-6 expression through p38 MAPK-dependent affinity changes with mRNA 3' untranslated region.Peripheral blood mononuclear phagocytes from patients with chronic periodontitis are primed for osteoclast formation.Interference RNA in immune-mediated oral diseases - minireview.Dual action of highbush blueberry proanthocyanidins on Aggregatibacter actinomycetemcomitans and the host inflammatory response.A Chemically Modified Curcumin (CMC 2.24) Inhibits Nuclear Factor κB Activation and Inflammatory Bone Loss in Murine Models of LPS-Induced Experimental Periodontitis and Diabetes-Associated Natural Periodontitis.
P2860
Q33881772-9C780FF5-9952-4CDA-84D6-D2D78369F15BQ35577020-9B73DDF6-C688-4E0F-88E5-9EBFD60F170AQ35725536-74ADE298-D598-4486-97B1-D98CDDCCFD41Q35963446-2C394ACD-C601-4B54-B3DB-3E61DA896CC3Q36235672-89913168-F930-4048-BB0C-499AF2C1E6DFQ37546949-551F5428-5296-43A4-A54B-D41BCCC03C84Q37691945-35CCB561-A9A4-4270-BBC1-1E50A1D5DB45Q38204892-C971DAC4-A154-4BC2-A49A-929A8F05D404Q38315680-030F3B68-6C10-428A-96BE-4C00425B5DFCQ38551613-5A469687-EB64-48BD-AC40-9A9DCB08A594Q41887469-17833AFB-1E6F-46F1-9A90-9E1C01C58327Q42279904-11032052-EB23-4454-B0DB-1EC5021483A4Q45272768-336378FC-61BA-418C-A6C8-24BB99968408Q47139740-19CD9B09-65FE-4852-B62A-D3D7AF207EBDQ49166585-14D53ED3-0ED5-4E77-967B-2C599DDE6864Q52866845-F1B0E516-B1F4-4AEA-8D1A-ADCB09D8D527
P2860
Silencing mitogen-activated protein kinase-activated protein kinase-2 arrests inflammatory bone loss.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Silencing mitogen-activated pr ...... rrests inflammatory bone loss.
@ast
Silencing mitogen-activated pr ...... rrests inflammatory bone loss.
@en
Silencing mitogen-activated pr ...... rrests inflammatory bone loss.
@nl
type
label
Silencing mitogen-activated pr ...... rrests inflammatory bone loss.
@ast
Silencing mitogen-activated pr ...... rrests inflammatory bone loss.
@en
Silencing mitogen-activated pr ...... rrests inflammatory bone loss.
@nl
prefLabel
Silencing mitogen-activated pr ...... rrests inflammatory bone loss.
@ast
Silencing mitogen-activated pr ...... rrests inflammatory bone loss.
@en
Silencing mitogen-activated pr ...... rrests inflammatory bone loss.
@nl
P2093
P2860
P356
P1476
Silencing mitogen-activated pr ...... rrests inflammatory bone loss.
@en
P2093
Bethany Herbert
Carlos Rossa
Keith L Kirkwood
Kylie Martin
Robert Zinna
P2860
P304
P356
10.1124/JPET.110.172395
P407
P577
2010-12-07T00:00:00Z